Subtypes | Lymphoma Hub

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing you cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Steering Committee About Us Sign Up Contact

Visit:

Steering Committee About Us Sign Up Contact

Subtypes Therapeutics Congresses Trials Expert Opinions

Lymphoma & CLL Subtypes

Find all the latest information in lymphoma and CLL, arranged by subtype and malignancy.

Aggressive B-cell lymphomas

Hodgkin lymphoma

Indolent B-cell lymphomas

Mantle cell lymphomas

Mature T and NK cell neoplasms

Monoclonal B-cell lymphocytosis

Rare lymphomas

Recently Added

Mature T and NK cell neoplasms

International T-cell Project: a subgroup analysis of patients with extranodal natural killer T-cell lymphoma

An analysis of data from a cohort of patients with ENKTL from the T-cell Project...

Apr 3, 2020

Brentuximab vedotin receives positive CHMP opinion in combination with CHP as treatment for adult patients with previously untreated sALCL

On March 31, 2020, the European Medicines Agency’s (EMA)...

Apr 2, 2020

Monoclonal B-cell lymphocytosis

Update on CLL induction therapy

An interview with Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR, on the first-line treatment of chronic lymphocytic leukemia (CLL).

Apr 3, 2020

Phase I–II clinical trial with CAR-NK cells against CD19-positive non-Hodgkin lymphoma or chronic lymphocytic leukemia

Results on the first 11 patients from an ongoing phase I–II clinical trial...

Mar 19, 2020

Hodgkin lymphoma

Nivolumab treatment followed by consolidation with allo-HSCT is associated with favorable outcomes in patients with relapsed/refractory Hodgkin lymphoma

Nivolumab is an immune checkpoint inhibitor...